ABBV vs JNJ
ABBV 与 JNJ 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | ABBVAbbVie Inc. | JNJJohnson & Johnson |
|---|---|---|
| 市值 | $451.60B | $645.90B |
| 市盈率(TTM) | 72.2 | 31.1 |
| 市净率 | — | 7.60 |
| 市销率 | 7.4x | 6.9x |
| 股息率 | 2.58% | 1.92% |
| 营收 | $61.16B(TTM) | $97.93B(TTM) |
| 营收同比增长 | 8.6% | 6.0% |
| 净利润 | $6.31B(TTM) | $21.04B(TTM) |
| 净利同比增长 | -1.2% | 90.6% |
| 每股收益(稀释) | $3.54(TTM) | $8.62(TTM) |
| 息税前利润率 | 24.6% | 22.9% |
| 净资产收益率 | — | 31.5% |
| 投入资本回报率 | 18.6% | 16.1% |
| 皮氏F值 | — | 6/9 |
| 一年总回报 | +26.1% | +55.7% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:ABBV vs JNJ
| 指标 | ABBV | JNJ |
|---|---|---|
| 期末价值 | $64.0K | $31.6K |
| 总回报 | +540.0% | +216.3% |
| 年化收益 (CAGR) | +19.7% | +11.8% |
| 波动率 | 25.9% | 18.6% |
| 夏普比率 | 0.68 | 0.48 |
| 索提诺比率 | 0.94 | 0.69 |
| 最大回撤 | -45.1% | -27.4% |
基于 2600 个共同交易日,2016-04-27 → 2026-08-28 · 无风险利率 3.9%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)